Photon Energy NV
- ISIN: NL0010391108
- Land: Niederlande
Nachricht vom 29.06.2020 | 16:34
Photon Energy to Increase 7.75% Bond 2017/2022
DGAP-News: Photon Energy NV
/ Key word(s): Bond
Photon Energy to Increase 7.75% Bond 2017/2022
- The bond's volume will be increased by up to EUR 5 million to EUR 45 million
- The bond will be offered in a private placement to qualified investors
- Net proceeds will be used to finance the construction of power plants for Photon Energy's own portfolio and to strengthen the company's financial standing
Additional notes issued under the 7.75% bond 2017/2022 (DE-000A19MFH-4) will be offered by Bankhaus Scheich Wertpapierspezialist AG, Frankfurt am Main, in a private placement to qualified investors in the Federal Republic of Germany and other countries, except for the United States of America, Canada, Australia and Japan.
As part of the increase, all existing bond terms remain unchanged. The bond, scheduled to mature in October 2022, bears interest at 7.75% a year and pays interest on a quarterly basis.
The Group intends to use the net proceeds from the bond increase to finance the construction of power plants in Hungary and Australia for its own PV-portfolio as well as to strengthen its financial standing.
The transaction will be managed by Bankhaus Scheich Wertpapierspezialist AG, Frankfurt am Main, as the sole global coordinator.
This announcement is for informational purposes only and does not constitute an offer to buy, sell, exchange or transfer any securities, or the solicitation of an offer to buy any securities of Photon Energy N.V. in the United States of America or any other jurisdiction. There will be no public offering of securities of Photon Energy N.V. The securities of Photon Energy N.V. referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the "Securities Act") and may not be offered or sold in the United States absent registration under the Securities Act. Neither Photon Energy N.V. nor any other party to the transaction described herein intends to register the securities described herein under the Securities Act or with any securities regulatory authority of any state or other jurisdiction in the United States of America in connection with this announcement. The securities may not be offered in any jurisdiction in any circumstances which require the preparation or registration of a prospectus or offer document relating to the securities in that jurisdiction.
In the United Kingdom, such information may be distributed only and is directed only at (i) professional investors within the meaning of Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), or (ii) high net worth companies falling within Article 49(2)(a) to (d) of the Order (all such persons together being referred to herein as "Relevant Persons"). The securities are available only to Relevant Persons and any invitation, offer or agreement to subscribe for, purchase or otherwise acquire such securities will be engaged in only with Relevant Persons. Any person who is not a Relevant Person should not act or rely on this announcement or its contents.
Subject to certain exceptions under the Securities Act, the securities referred to in this announcement may not be offered or sold in Australia, Canada or Japan, or to or for the account of persons resident in Australia, Canada or Japan.
Neither Photon Energy N.V. nor any of its affiliates has taken any action that would permit a public offering of the securities or the possession or distribution of this announcement or any other offer or solicitation in connection with the securities in any jurisdiction where such action is required. In Member States of the European Economic Area ("EEA"), this announcement and any subsequent offer is directed only at persons who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129 ("Qualified Investors"). Any person in the Relevant Member States who acquires or is offered securities (an "Investor") in connection with an Offer is deemed to have represented and agreed to be a Qualified Investor. Each investor is further assumed to have represented and agreed that the securities it has acquired under the Offer will not be acquired for persons in the EEA other than Qualified Investors or persons in the United Kingdom or other Member States (having similar laws) for whom the investor has the discretion to make decisions and that the securities have not been acquired for offering or resale in the EEA if this would result in Photon Energy N.V. or any of its affiliates being required to publish a prospectus pursuant to Article 3 of Regulation (EU) 2017/1129.
This announcement contains forward-looking statements that are subject to certain risks and uncertainties. Future results could differ materially from those described in these forward-looking statements due to various factors, including changes in business, economic and competitive conditions, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings and the availability of financing. Photon Energy N.V. assumes no responsibility to update any forward-looking statements contained in this release.
International School Augsburg (ISA) – erste Schule in Deutschland geht an die Börse
Die International School Augsburg – ISA- gemeinnützige AG geht als erste Schule in Deutschland an die Börse und macht damit erstmals das Thema „Bildung“ unter ESG-Kriterien investierbar. Mit dem geplanten Emissionserlös soll ein Campus-Neubau finanziert werden, um die hohe Nachfrage bedienen zu können. In unserer Researchstudie haben wir die hohe Bedeutung der ISA für den regionalen Wirtschaftsstandort, eine hohe Stabilität der Geschäftsentwicklung sowie hohe Sicherheiten durch vorhandene Sachwerte ermittelt. Das Rating lautet KAUFEN.
Der AKTIONÄR News
25. Februar 10:25 Apple Car: „BMW wäre der ideale Partner“
25. Februar 10:15 Plug Power vor den Zahlen: Das macht Anlegern Mut
25. Februar 09:45 Geely: Fusion vom Tisch – Aktie mit 134 Prozent Gewinn verkauft
25. Februar 09:39 BioNTech-Konkurrent Moderna: Spezial-Impfstoff für südafrikanische ...
25. Februar 09:35 Kommentar von Lars Brandau: Enger Fokus bei Basiswerten: Holt die ...
News im Fokus
Fresenius Medical Care AG & Co. KGaA veröffentlicht Form 20-F für das Geschäftsjahr 2020
24. Februar 2021, 10:51
FY 2020 prelim. results
24. Februar 2021
Original-Research: Nynomic AG (von Montega AG): Kaufen
25. Februar 2021